Barclays’s Amrize Ltd AMRZ Stock Holding History

Barclays’s Portfolio AMRZ Stock Details AMRZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-28,400	Closed	-$1.38M	–	5836
2025 Q3	$1.38M	Buy	+28,400	New	+$1.45M	﹤0.01%	3163

Other funds holding AMRZ

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Zurich Cantonal Bank Zurich, Switzerland $46B AUM 27.59% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Barclays's AMRZ Position: Q1 2026 in Review

Barclays reduced its Amrize Ltd (AMRZ) stake by 53% in Q1 2026, selling an estimated $141M and leaving 2,157,044 shares worth $121M. The position accounts for 0.03% of the portfolio, ranked #436.

Barclays first reported a position in AMRZ in Q2 2025 and has held it in 4 quarters since. The position peaked at $250M in Q4 2025. 447 funds tracked by Wall St. Rank hold AMRZ as of Q1 2026.

Barclays held 2,157,044 shares of Amrize Ltd worth $121M as of Q1 2026.
Barclays sold 2,457,549 Amrize Ltd shares in Q1 2026, an estimated $141M.
Amrize Ltd made up 0.03% of Barclays's portfolio in Q1 2026, its #436 holding.
Barclays first reported a position in Amrize Ltd in Q2 2025 and has held it in 4 quarters since.
Barclays's Amrize Ltd position peaked at $250M in Q4 2025.
447 funds tracked by Wall St. Rank held Amrize Ltd as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.